Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.


Recall -- Firm Press Release


FDA posts press releases and other notices of recalls and market withdrawals from the firms involved as a service to consumers, the media, and other interested parties. FDA does not endorse either the product or the company.


ForeCYTE Breast Health Test; Mammary Aspiration Specimen Cytology Test (MASCT)



FOR IMMEDIATE RELEASE - October 4, 2013 -Atossa Genetics Inc. (NASDAQ: ATOS) initiated a voluntary recall to remove the ForeCYTE Breast Health Test and the Mammary Aspiration Specimen Cytology Test (MASCT) device from the market. This voluntary recall includes the MASCT System Kit and Patient Sample Kit. The vast majority of these products (approximately ninety percent) are in inventory with Atossa’s distributors and the remaining quantities are at customer sites across the United States. Distributors and customers should stop using affected products and return them to Atossa immediately.

Atossa is removing the ForeCYTE Breast Health Test and the MASCT device from the market to address concerns raised by the U.S. Food and Drug Administration (FDA) in a warning letter received by Atossa in February 2013. The FDA raised concerns about (1) the current instructions for use (IFU); (2) certain promotional claims used to market these devices; and (3) the need for FDA clearance for certain changes made to the Nipple Aspirate Fluid (NAF) specimen collection process identified in the current IFU. Atossa will remove existing product from the market until FDA’s concerns are addressed.

The MASCT device has been cleared by the FDA for use as a sample collection device, with the provision that the fluid collected using this device can be used to determine and/or differentiate between normal, pre-cancerous, and cancerous cells. The MASCT device has not been cleared by the FDA for the screening or diagnosis of breast cancer. In addition, the ForeCYTE Breast Health Test has not been cleared or approved by the FDA for any indication. The ForeCYTE Breast Health Test and the MASCT device are not a replacement for screening mammograms, diagnostic imaging tests, or biopsies. Patients should follow the recommendations and instructions of their physician with respect to breast cancer screening and diagnosis.

To date, Atossa is unaware of any adverse incidents or injuries associated with the use of the ForeCYTE Breast Health test and the MASCT device or the processing method currently identified in the IFU. Additionally, Atossa is unaware of any risk to health or injury for clinicians or the patient population that have used these devices. However, these devices may produce false positive or false negative results. Although not cleared or intended for this use, if these devices are used as a substitute for recommended screening or diagnosis of breast cancer, FDA is concerned that patients may choose to forgo recommended mammograms and necessary biopsies.

Atossa is working with the FDA on this matter and this voluntary recall. Atossa is notifying its distributors and customers by certified mail and is arranging for the return of all recalled product(s). Products affected by this recall are listed in the table below (table 1):


Product CodePart NumberDescriptionLot Number
AG-MASCT9002528MASCT System KitsAll
AG-MASCT9002528MDMASCT System KitsAll
DTG-MASCT9002587Clarity System KitsAll
AG-FC59002513MASCT Patient Sample KitsAll
AG-FC59002513MDMASCT Patient Sample KitsAll
DTG-FC59002614Clarity Patient Sample KitsAll
NRLBH-59002717MDNipple Aspirate Fluid Laboratory KitAll


MASCT System Kit

  1. MASCT Breast Pump
  2. Instructions for Use (IFU)
  3. Heating Pad
  4. Timer
  5. Saccomono’s Fixative
  6. Nu Prep Gel
  7. Welcome and Training Materials Coversheet
  8. MASCT System Order Form
  9. ForeCYTE Training Video DVD
  10. MASCT System Instructions with pictures - pink


Patient Sample Kit

  1. Two (2) flower assemblies (e.g., filter, filter retainer, and filter holder),
  2. Instructions for Use (IFU)
  3. Two (2) specimen collection devices,
  4. Two (2) breast bags for transporting the specimen collection container
  5. Barcode labels
  6. Saccomono’s Fixative
  7. Nu Prep Gel
  8. MASCT System package insert
  9. ForeCYTE Test Requisition Form
  10. Patient Information Sheet
  11. Atossa Patient Information
  12. FED EX Clinical PAK
  13. MASCT System Order Form
  14. FED EX Pouch
  15. FED EX Airbill

Distributors and customers should contact Atossa at 800-351-3902 to obtain instructions on how to return these products. Customers with questions may contact the company via telephone at 1-888-219-4629 at any time.

Any problems experienced with the use of this product may be reported to the FDA: at

Online (form available to fax or mail), or call FDA 1-800-FDA-1088


RSS Feed for FDA Recalls Information [what's this?]

Page Last Updated: 10/04/2013
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English